KWM
Kingsview Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $477K | Hold |
908
| – | – | 0.01% | 783 |
|
|
2025
Q1 | $576K | Sell |
908
-94
| -9% | -$59.6K | 0.01% | 683 |
|
|
2024
Q4 | $714K | Buy |
1,002
+142
| +17% | +$101K | 0.01% | 641 |
|
|
2024
Q3 | $904K | Buy |
860
+22
| +3% | +$23.1K | 0.02% | 560 |
|
|
2024
Q2 | $881K | Buy |
838
+34
| +4% | +$35.7K | 0.02% | 545 |
|
|
2024
Q1 | $774K | Hold |
804
| – | – | 0.02% | 568 |
|
|
2023
Q4 | $706K | Buy |
804
+10
| +1% | +$8.78K | 0.02% | 559 |
|
|
2023
Q3 | $653K | Buy |
794
+108
| +16% | +$88.9K | 0.02% | 550 |
|
|
2023
Q2 | $493K | Sell |
686
-1
| -0.1% | -$719 | 0.02% | 592 |
|
|
2023
Q1 | $564K | Sell |
687
-21
| -3% | -$17.3K | 0.02% | 543 |
|
|
2022
Q4 | $511K | Sell |
708
-114
| -14% | -$82.3K | 0.02% | 504 |
|
|
2022
Q3 | $566K | Buy |
822
+91
| +12% | +$62.7K | 0.03% | 471 |
|
|
2022
Q2 | $432K | Buy |
731
+22
| +3% | +$13K | 0.02% | 569 |
|
|
2022
Q1 | $495K | Buy |
709
+18
| +3% | +$12.6K | 0.02% | 573 |
|
|
2021
Q4 | $436K | Sell |
691
-125
| -15% | -$78.9K | 0.02% | 610 |
|
|
2021
Q3 | $494K | Buy |
816
+115
| +16% | +$69.6K | 0.02% | 546 |
|
|
2021
Q2 | $403K | Buy |
701
+50
| +8% | +$28.7K | 0.02% | 616 |
|
|
2021
Q1 | $309K | Buy |
651
+23
| +4% | +$10.9K | 0.02% | 631 |
|
|
2020
Q4 | $303K | Sell |
628
-367
| -37% | -$177K | 0.02% | 550 |
|
|
2020
Q3 | $557K | Sell |
995
-25
| -2% | -$14K | 0.05% | 343 |
|
|
2020
Q2 | $636K | Sell |
1,020
-62
| -6% | -$38.7K | 0.06% | 283 |
|
|
2020
Q1 | $528K | Buy |
+1,082
| New | +$528K | 0.07% | 260 |
|